Open AccessOutcomes of immunomodulatory and biologic therapy in people living with HIV
Author(s) -
Michael J. Peluso,
Jessica Chen,
Sadie E. Munter,
Asia Reed,
Justin Teraoka,
Ingrid EshunWilson,
Timothy J. Henrich,
Peter ChinHong
Publication year - 2020
Publication title -
aids
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.195
H-Index - 216
eISSN - 1473-5571
pISSN - 0269-9370
DOI - 10.1097/qad.0000000000002549
Subject(s) - concomitant , medicine , regimen , cohort , retrospective cohort study , human immunodeficiency virus (hiv) , viral load , immunology , oncology
Immunomodulatory drugs (IMDs) are crucial for treating autoimmune, inflammatory, and oncologic conditions. Data regarding the safety of IMDs in people living with HIV (PLWH) are limited. We describe outcomes in all PLWH prescribed these agents from 2000--2019 at two academic medical centers.